Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-interferon and its effects on signalling pathways within cells.

Michele Caraglia1, Giovanni Vitale, Monica Marra

  • 1Dipartimento di Biochimica e Biofisica, Seconda Universita di Napoli, Via Costantinopoli, 16 80138, Naples, Italy.

Current Protein & Peptide Science
|December 8, 2004
PubMed
Summary

Interferon-alpha (IFNalpha) can induce cancer cell apoptosis via STAT-dependent pathways. However, tumor cells can resist this by activating the EGF-mediated Ras/Erk pathway, suggesting this pathway could be targeted to enhance IFNalpha therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Cancer in migrant populations: evidence from a regional oncology network.

BMC public health·2026
Same author

Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.

Cell death & disease·2026
Same author

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer.

Journal of experimental & clinical cancer research : CR·2025
Same author

Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma.

Journal of translational medicine·2025
Same author

Testicular Tumors and Environmental Pollution: A Comparative Oncoepidemiology Study in the Campania Region from 2020 to 2023.

Veterinary sciences·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferon-alpha (IFNalpha) is a recombinant cytokine used in cancer therapy.
  • Its precise mechanisms for suppressing tumor growth and inducing apoptosis are not fully understood.
  • IFNalpha is known to regulate cancer cell growth, differentiation, and signaling pathways.

Purpose of the Study:

  • To review the established Signal transducer and activator of transcription (STAT)-dependent mechanisms of IFNalpha.
  • To explore the proposed mechanisms of IFNalpha-induced apoptosis, including stress-dependent kinase pathways and protein synthesis modulation.
  • To investigate tumor resistance mechanisms to IFNalpha, particularly the role of epidermal growth factor (EGF)-mediated Ras/extracellular signal regulated kinase (Erk) signaling.

Main Methods:

Related Experiment Videos

  • Review of existing literature on IFNalpha signaling and apoptosis induction.
  • Discussion of studies on stress-dependent kinase pathways and protein synthesis machinery.
  • Analysis of in vitro studies investigating tumor resistance to IFNalpha.
  • Examination of the role of EGF-mediated Ras/Erk signaling in protecting tumor cells from IFNalpha-induced apoptosis, using methods like RASN17 transfection and Mek-1 inhibition.

Main Results:

  • IFNalpha's STAT-dependent mechanism of action is well-established.
  • Tumor cells can develop resistance to IFNalpha through alterations in JAK-STAT signaling components.
  • A novel resistance mechanism involves EGF-mediated Ras/Erk signaling, which protects tumor cells from IFNalpha-induced apoptosis.
  • Ras/Erk pathway involvement was confirmed by Ras inactivation and Mek-1 inhibition.

Conclusions:

  • Targeting the Ras/Erk pathway may enhance the anti-tumor activity of IFNalpha.
  • Understanding these resistance mechanisms provides new insights for improving IFNalpha-based cancer therapies.
  • Further research into specific pathway disruptions could potentiate IFNalpha's effectiveness against human tumors.